[Biological backgrounds of the hyperkinetic syndrome].
D001143:Arousal / Q000502:physiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy; D001921:Brain / Q000503:physiopathology*; D001927:Brain Diseases / Q000175:diagnosis; D002395:Catecholamines / Q000502:physiology; D002540:Cerebral Cortex / Q000254:growth & development; D002648:Child; D002657:Child Development / Q000502:physiology; D004569:Electroencephalography; D006624:Hippocampus / Q000503:physiopathology; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects; D018377:Neurotransmitter Agents / Q000502:physiology; D011613:Psychotherapy / Q000379:methods; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D012154:Reticular Formation / Q000503:physiopathology; D009626:Terminology as Topic
D002395:Catecholamines; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D008774:Methylphenidate
Biologische achtergronden van het hyperkinetische syndroom.